Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy. [electronic resource]
Producer: 20141001Description: 38-42 p. digitalISSN:- 1598-6357
- Adalimumab
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Enzyme Inhibitors -- adverse effects
- Etanercept
- Female
- Humans
- Hydroxychloroquine -- adverse effects
- Immunoglobulin G -- adverse effects
- Immunosuppressive Agents -- adverse effects
- Infliximab
- Interferon-gamma Release Tests
- Male
- Methotrexate -- adverse effects
- Middle Aged
- Mycobacterium tuberculosis -- isolation & purification
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Retrospective Studies
- Spondylitis, Ankylosing -- drug therapy
- Tuberculin Test
- Tuberculosis -- chemically induced
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.